Skip to main content
  • Register
  • Help
  • Contact us
  • Log out of your HL account

NanoViricides Inc (NNVC) USD0.001

Sell:$0.16 Buy:$0.26 Change: $0.0086 (4.27%)
Market closed |  Prices as at close on 23 August 2019 | Switch to live prices |
Sell:$0.16
Buy:$0.26
Change: $0.0086 (4.27%)
Deal now Deal for just £11.95 per trade in a ISA, Lifetime ISA, SIPP or Fund & Share Account
Market closed |  Prices as at close on 23 August 2019 | Switch to live prices |
Sell:$0.16
Buy:$0.26
Change: $0.0086 (4.27%)
Market closed |  Prices as at close on 23 August 2019 | Switch to live prices |
Deal now Deal for just £11.95 per trade in a ISA, Lifetime ISA, SIPP or Fund & Share Account
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

NanoViricides, Inc. is a nano-biopharmaceutical company. The Company is a development-stage company with several drugs in various stages of development. The Company focuses on its research and clinical programs on specific anti-viral therapeutics. The Company is engaged in the application of nanomedicine technologies to the issues of viral diseases. The Company's nanoviricide technology enables direct attacks at multiple points on a virus particle. In addition, the nanoviricide technology also simultaneously enables attacking the intracellular reproduction of the virus by incorporating one or more active pharmaceutical ingredients (APIs) within the core of the nanoviricide. The nanoviricide technology is engaged in both attacking extracellular virus thereby breaking the reinfection cycle, and simultaneously disrupting intracellular production of the virus, thereby enabling complete control of a virus infection.

Contact details

Address:
1 Controls Dr
SHELTON
06484-6153
United States
Telephone:
+1 (203) 9376137
Website:
www.nanoviricides.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
NNVC
ISIN:
US6300872032
Market cap:
$17.39 million
Shares in issue:
76.74 million
Sector:
Biotechnology
Exchange:
New York Stock Exchange
Country:
United States
Currency:
US dollar
Indices:
n/a

Key personnel

  • Anil Diwan
    Chairman of the Board, President
  • Meeta Vyas
    Chief Financial Officer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.
Deal now Deal for just £11.95 per trade in a ISA, Lifetime ISA, SIPP or Fund & Share Account

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.